Testing early kidney marker tests for people with diabetes
Part of Hormones & metabolism, Kidney & urinary clinical trials.
This study looks for early warning signs in blood or other samples (using a special lab approach) to detect kidney problems sooner in people with diabetes. It may help patients and clinicians identify kidney risk earlier and follow changes over many years.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are willing to sign consent to join the study
- You are age 20 to 80, and you can be any gender
- You can follow the study plan and have follow-up data available for more than 5 years
- Your kidney disease is caused by diabetes (not another kidney condition)
- You do not have a current serious infection or illness that could interfere with the study
- Your overall health is expected to allow at least 5 more years of life
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial focuses on improving how kidney damage is diagnosed and how treatment is planned for people with type 2 diabetes and kidney disease. It may help by using detailed medical history and (if done) kidney biopsy results to guide care more accurately.
This study is testing a new way to find early signs of kidney damage in people with diabetes. The goal is to catch kidney disease (diabetic nephropathy) sooner, so it can be managed more effectively.
This study looks at simple blood tests to see if certain markers of inflammation and platelet levels are different in people with diabetic kidney disease compared to healthy people. The results might help doctors find kidney problems earlier in people with type 2 diabetes.
This study looks at whether two simple blood tests (a measure of insulin resistance and certain inflammation markers) can help predict how diabetic kidney disease will progress. If you have diabetes and early kidney problems, this might help your doctor better understand your condition.
This study looks at two blood markers in people with diabetic kidney disease to see if they relate to the condition. It may help doctors understand the disease better and could lead to better monitoring or treatment in the future.
This trial tests a new system to manage diabetic kidney disease across all stages. It is for people with type 2 diabetes who either have no kidney damage or have kidney damage confirmed by a biopsy.
Hear when a new Diabetic Nephropathy Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.